Evidence map›Paper›PMID 30694830›Full record

ReviewCurrent opinion in endocrinology, diabetes, and obesity2019

Risk factors for valvular calcification.

Hao Yu Chen, James C Engert, George Thanassoulis

Abstract readReview
In one paragraph

Review in Current opinion in endocrinology, diabetes, and obesity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Ten-year trajectory of Life's Essential 8 and aortic valve calcification.American journal of preventive cardiology · 2026
    Article
  3. Review
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
  9. Dysglycaemia and incident aortic stenosis: a cohort study.Heart (British Cardiac Society) · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Aortic stenosis: a review on acquired pathogenesis and ominous combination with diabetes mellitus.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hao Yu ChenDivision of Experimental Medicine, McGill University.
James C EngertDivision of Experimental Medicine, McGill University.
George ThanassoulisDivision of Experimental Medicine, McGill University.
McGill University · CAMcGill University Health Centre · CA

Funding

Molecular and Genetic Epidemiology of Lp(a)-mediated Calcific Aortic Valve DiseaseR01HL128550 · NHLBI · MCGILL UNIVERSITY HEALTH CTR RES INST · PI THANASSOULIS, GEORGE · 2017 to 2020
$1.7M
CIHRNHLBI NIH HHS R01 HL128550
6 · The paper itself

Abstract

purpose of reviewRecent literature is examined to identify established and emerging risk factors for valvular calcification, specifically calcific aortic valve disease and mitral annular calcification. RECENT

findingsStrong evidence implicates older age, male sex, cigarette smoking, elevated blood pressure, dyslipidaemia, adiposity, and mineral metabolism as risk factors for calcific aortic valve disease. Emerging evidence suggests family history and lipoprotein(a) are additional risk factors. Recently, large-scale genome-wide analyses have identified robust associations for LPA, PALMD, and TEX41 with aortic stenosis. Factors predisposing to mitral annular calcification are less well characterized. Older age, cigarette smoking, increased BMI, kidney dysfunction, and elevated triglycerides are associated with greater risk of mitral annular calcification, but conflicting evidence exists for sex and C-reactive protein. SUMMARY: Established and emerging risk factors for calcific aortic valve disease, including some that overlap with atherosclerosis, may represent targets for pharmacological intervention. Mitral annular calcification is comparatively less well understood though some atherosclerosis risk factors do appear to increase risk.

Indexed as

Mitral ValveAge FactorsAortic ValveAortic Valve StenosisCalcinosisFemaleHeart Valve DiseasesHumansMaleRisk Factors

Identifiers

PMID30694830
PMCPMC6873465
OpenAlexW2912503275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.